# FDA 483 - Laura Mulloy, D.O. - September 11, 2019

Source: https://www.keypedia.com/records/483/laura-mulloy-do/c14217c4-97e5-4b04-a83f-5d763611723c

> FDA 483 for Laura Mulloy, D.O. on September 11, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Laura Mulloy, D.O.
- Inspection Date: 2019-09-11
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Dr. Laura L. Mulloy, D.O., a clinical investigator in Augusta, GA, revealed two significant issues. The firm's investigational drug disposition records were inadequate, leading to discrepancies in drug accountability and an inability to verify administered dosages. Additionally, the inspection found multiple instances where informed consent was not obtained from human subjects prior to performing study-related tests.

## Related Officers

- [investigator](https://www.keypedia.com/people/sereen-g-morgan-murray/1900ad73-5999-471e-8f74-63627bd1aa2a)

Company: https://www.keypedia.com/companies/laura-mulloy-do/d275f737-b46f-456a-9b5d-00485c98ab7a

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7